SCHEMBL7626879

SCHEMBL7626879

CC(=O)Oc1ncc2[nH]cnc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.44
▸ CDK2 P24941 2/20 0.38
▸ PAK1 Q13153 1/20 0.36
▸ CCNT1 O60563 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CCNB1 P14635 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ CCNH P51946 1/20 0.35
▸ MGMT P16455 2/20 0.35
▸ PDE5A O76074 1/20 0.35
▸ POLA1 P09884 1/20 0.34
▸ GDA Q9Y2T3 1/20 0.33
▸ MAP3K7 O43318 1/20 0.32
▸ MAP3K6 O95382 1/20 0.32
▸ MAP3K5 Q99683 1/20 0.32
▸ F2 P00734 1/20 0.31
▸ GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8411934 0.81 ALDH1A1 (0.44) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL1398871 0.78 ALDH1A1 (0.53) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL30514135 0.77 ALDH1A1 (0.57) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL30377278 0.77 ALDH1A1 (0.40) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL7771676 0.75 ALDH1A1 (0.50) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL2894579 0.75 KDM4E (0.50) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL7626864 0.74 ALDH1A1 (0.34) ALDH1A1GDAF2GLAHPGD
SCHEMBL6027523 0.71 ALDH1A1 (0.46) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL5196386 0.71 CDK2 (0.51) ALDH1A1KDM4ERXFP1CDK2PAK1
SCHEMBL30119558 0.71 ALDH1A1 (0.46) ALDH1A1KDM4ERXFP1CDK2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114994160-A Analysis method for detecting formaldehyde-treated protein/polypeptide/amino acid food/product 天津医科大学 2022-09-02 — — CN claimed
CN-101107249-B purine derivatives as A2A receptor agonists NOVARTIS AG 2010-10-13 — — CN disclosed
CN-101107249-A Purine derivatives as A2A receptor agonists NOVARTIS AG (CH) 2008-01-16 — — CN disclosed
CN-1315835-C Polycyclic guanine phosphodiesterase v inhibitors SCHERING CORP (US) 2007-05-16 — — CN disclosed
CN-1781920-A Polycyclic guanine phosphodiesterase v inhibitor SCHERING PLOUGH CORP (US) 2006-06-07 — — CN disclosed
CN-1547583-A Polycyclic guanine phosphodiesterase v inhibitors ���鹫˾ 2004-11-17 — — CN disclosed
EP-1177202-A1 4'-C-ETHYNYL PURINE NUCLEOSIDES YAMASA CORPORATION (JP) 2002-02-06 — — EP disclosed
EP-1177201-A1 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES YAMASA CORPORATION (JP) 2002-02-06 — — EP disclosed
WO-2000069877-A1 4'-C-ETHYNYL PURINE NUCLEOSIDES YAMASA CORPORATION (JP) 2000-11-23 — — WO disclosed
WO-2000069876-A1 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES YAMASA CORPORATION (JP) 2000-11-23 — — WO disclosed
Send feedback